Fact CheckerSign in

NCT07030335Not yet recruiting

Evaluation of Mobile Education Program in Patients With Atrial Fibrillation.

The Effect Of A Mobıle Educatıon Program and Telephone Follow-Up On Knowledge Level, Symptom Management And Qualıty Of Lıfe In Patıents Wıth Atrıal Fıbrıllatıon

Source: ClinicalTrials.gov · Last updated 22 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study was conducted to determine the effect of a mobile education program and telephone follow-up on the knowledge level, symptom management and quality of life of patients with atrial fibrillation. The study aims to answer the following questions. 1. Does the mobile education program and telephone follow-up have an effect on increasing the level of knowledge in patients with AF in the intervention group compared to the control group? 2. Does the mobile education program and telephone follow-up have an effect on reducing symptom severity in patients with AF in the intervention group compared to the control group? 3. Does the mobile education program and telephone follow-up have an effect on improving the quality of life in patients with AF in the intervention group compared to the control group?

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
27 May 2025
Start date
Jun 2025
Primary completion date
Jul 2025
Lead sponsor
Akdeniz University
NCT number
NCT07030335

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From Jun 2025 to the primary completion date, Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Diagnosis of rheumatic valve disease, moderate/severe mitral stenosis and previous valve surgery.

Other illness

  • Functional class III or IV according to the New York Heart Association (NYHA) classification.

Other

  • Patients with existing or planned pacemaker, ICD (Implantable Cardioverter Defibrillator) and patients with existing or planned Radiofrequency Ablation treatment will not be included in the study.

Who the study is looking for

  • 18 years of age or older.
  • Being literate.
  • Atrial Fibrillation diagnosis.
  • No cognitive and communication disabilities.
  • Not having a diagnosed psychiatric illness.
  • Ability to use technological devices.
  • Having and using a smart phone with Android operating system and internet access.
  • Acceptance to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Akdeniz University Hospital Cardiology Polyclinic
Coordinator of this site? Confirm its status
AntalyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.